As a final proof of concept application of our antibodies, we tested to see whether CDCP1 expression level could be used as an in vivo imaging marker for RAS signaling in a mouse xenograft model for pancreatic cancer (Figure 5G). The gene discussed is CDCP1; the disease is pancreatic neoplasm.